• Latest Posts

New Discovery unites Australia, Germany and UK Against Blood Cancers

Alphabody Platform for Cancer Draws in €260M Discovery Deal with MSD

ADC Approval Buoys Spirits in Cancer Treatment Space

MSD Enters Covid-19 Vaccine Race by Acquiring Themis Bioscience

Austrian Vaccine Developer Signs Deal with MSD in ‘Blockbuster Indication’

MSD Offers €464M to Buy German Biotech Fighting Cancer with RNA

In Depth 9 Apr 2018

Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?

German Biotech Unveils Positive Phase II Results for Alzheimer’s

Berlin Biotech Advances its Cancer Drug in a New Trial with Keytruda

TCR and Checkpoint inhibitors: A Match made in Heaven for Blood Cancer

UPDATE: Sanofi defeated in the Race to acquire Medivation

And now, Immuno-oncology gets EMA’s pre-approval for Lung Cancer